spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

ERT Launches the Industrys First Multi-Language Diagnostic Platform for Respiratory Trials

ERT

Native language capabilities significantly improve site performance and clinical data quality

PHILADELPHIA – December 5, 2016 –– ERT, a leading provider of high-quality patient data collection solutions for use in clinical drug development, today announced a significant enhancement to MasterScope™, the company’s flagship platform for centralized respiratory clinical trials, making it the industry’s first and only multi-language solution.

With multi-language capabilities, MasterScope enables sites to manage respiratory trials in their native language, which saves time, reduces the risk of protocol compliance errors, and improves overall data quality. Sponsors can now confidently expand the scope of countries in their trials, removing language as a barrier to site performance.

“Respiratory trials are highly complex, requiring investigative site personnel to guide patients through precise maneuvers in order to collect accurate data that supports drug efficacy and safety claims,” said Achim Schülke, Executive Vice President, Respiratory Solutions at ERT. “Assuming all site personnel and patients can comprehend English well enough to accurately follow these workflows is impractical. With these enhancements to MasterScope, sponsors running global cardiopulmonary trials can now add native language capabilities to reduce another level of risk while increasing site compliance.”

ERT’s MasterScope supports any clinical trial that requires spirometry measurements, including those that also collect Fractional exhaled Nitric Oxide (FeNO), electrocardiogram (ECG), home spirometry, and electronic Clinical Outcome Assessment (eCOA) data.

For more information on ERT’s suite of Respiratory Solutions, visit http://www.ert.com/respiratory.
phone +1 800 961 5004
email eresearch@ert.com
web www.ert.com
email 1818 Market Street, Suite 1000, Philadelphia, PA 19103
 
Print this page
Send to a friend
   
spacer
News and Press Releases

WORLD’S FIRST PCM CARGO COVER

A British team of scientists at TLX Cargo Ltd have invented the worlds Cargo Cover/Thermal blanket that incorporates Phase Change Material (PCM) into it`s structure, solved the problem of hot lane temperature excursions on the tarmac.
More info >>


White Papers

Bringing more control to temperature-sensitive logistics

UPS Supply Chain Solutions

By 2016, world sales of cold-chain drugs and biologics such as vaccines and blood plasma products will near $240 billion1. The increase has led to a surge in discussion about how to protect these products throughout the transportation logistics cycle. Industry experts are recommending that the term “cold chain” be eliminated from rules, guidance and best-practice documents. “Cold chain” now includes a broader spectrum of temperature ranges, such as controlled room temperature (CRT). This white paper focuses on the initial steps required to establish a temperature-sensitive supply chain.
More info >>

Industry Events

T3: Trials, Tech and Transformation

30-31 May 2018, Raleigh Convention Center, Raleigh, NC

T3 is back for 2018 to provide you with the latest updates and top tips from across the clinical trials landscape. Connecting leading experts, influencers and innovators from pharma, biotech, CROs, patient advocacy groups, academia and beyond, T3 is themeeting place for all stakeholders to voice their questions, connect with peers, and get direct feedback from an expert speaker line-up.And this year, we're in Raleigh.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement